Loading...

Home
ETF
ALKS

ALKS

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ALKS News

Alkermes Shares Plunge 31% After Phase 2 Study Results

3d agoseekingalpha

Alkermes Reports Positive Phase 2 Results for Alixorexton in Narcolepsy Type 2

3d agoNewsfilter

Alkermes Receives Orphan Drug Designation for Alixorexton

5d agoNASDAQ.COM

Alkermes Receives FDA Orphan Drug Designation

Jun 11 2026seekingalpha

Alkermes' Lumryz Achieves Key Trial Milestone for Sleep Disorder

May 12 2026seekingalpha

Alkermes Q1 Earnings Announcement Scheduled

May 04 2026seekingalpha

Analysis of XBI ETF Trading Dynamics

Apr 07 2026NASDAQ.COM

Alkermes Shares Surge 15% Following Lilly-Centessa Deal

Mar 31 2026stocktwits

Alkermes Launches Mental Health Nursing Grant Program

Mar 12 2026Newsfilter

Alkermes 2026 Financial Outlook and Acquisition Progress

Feb 25 2026seekingalpha

Alkermes Reports Decline in Q4 Earnings

Feb 25 2026NASDAQ.COM

Alkermes Reports 2025 Financial Results and 2026 Outlook

Feb 25 2026Newsfilter

Alkermes Q4 Earnings Report Analysis

Feb 25 2026seekingalpha

Alkermes Set to Announce Q4 Earnings on February 25

Feb 24 2026seekingalpha

Key Wall Street Rating Changes Overview

Feb 24 2026CNBC

Wall Street Analysts Adjust Ratings

Feb 20 2026Benzinga